Cargando…

Anti-vascular endothelial growth factor treatment regimens preference by choroidal neovascularization patients under COVID-19

Detalles Bibliográficos
Autor principal:	Au, Sunny Chi Lik
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2020
Materias:	Letters to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7727992/ https://www.ncbi.nlm.nih.gov/pubmed/32971709 http://dx.doi.org/10.4103/ijo.IJO_1799_20

Ejemplares similares

Autofluorescence findings and role of anti-vascular endothelial growth factor in inflammatory choroidal neovascular membrane
por: Chhablani, Jay Kumar
Publicado: (2010)

Anti-vascular endothelial growth factor drugs in polypoidal choroidal vasculopathy
por: Chhablani, Jay Kumar
Publicado: (2011)

A surge in eye clinic nonattendance under 2019 novel coronavirus outbreak
por: Au, Sunny Chi Lik
Publicado: (2020)

Response of Pediatric Choroidal Neovascularization to Anti-Vascular Endothelial Growth Factor
por: Ruparelia, Sunil, et al.
Publicado: (2021)

Performing hyperbaric oxygen therapy for central retinal artery occlusion under COVID-19: From myringotomy to rapid viral test
por: Sunny, Chi Lik Au
Publicado: (2021)

Big data are needed for analysis of the association of retinal vascular occlusion and COVID-19
por: Lam, Wai Yan, et al.
Publicado: (2023)

Anti-vascular endothelial growth factor therapy for the treatment of myopic choroidal neovascularization
por: Tan, Colin S, et al.
Publicado: (2017)

Anti-vascular endothelial growth factors for choroidal neovascularization secondary to choroidal osteoma: Long-term results
por: Lekha, T., et al.
Publicado: (2015)

Characteristics and response of subretinal hyperreflective material to anti-vascular endothelial growth factor in myopic choroidal neovascularization
por: Huang, Chien-Jung, et al.
Publicado: (2023)

Results of Intravitreal Anti-Vascular Endothelial Growth Factor Therapy in Inflammatory Choroidal Neovascularization
por: Zina, Sourour, et al.
Publicado: (2021)

Prevalence of SARS-CoV-2 among central retinal vein occlusion patients
por: Sunny,, et al.
Publicado: (2021)

Comment on: Retinal manifestations in patients following COVID-19 infection
por: Au, Sunny Chi Lik
Publicado: (2021)

Central retinal artery occlusion in COVID-19
por: Au, Sunny Chi Lik
Publicado: (2021)

Comments on Stroke as a Neurological Complication of COVID-19: A Systematic Review and Meta-Analysis of Incidence, Outcomes and Predictors
por: Au, Sunny Chi Lik
Publicado: (2021)

Comment on: Outcomes of combined treatments in patients with retinal arterial macroaneurysm
por: Au, Sunny Chi Lik
Publicado: (2022)

Comments on: After the Storm: Ophthalmic Manifestations of COVID-19 Vaccines
por: Au, Sunny Chi Lik
Publicado: (2022)

Surgical choroidal neovascular membrane removal in the era of anti-vascular endothelial growth factor agents
por: Nagpal, Manish, et al.
Publicado: (2009)

Evaluation of efficacy and recurrence for anti-vascular endothelial growth factor therapy in idiopathic choroidal neovascularization
por: Wu, Qianru, et al.
Publicado: (2020)

Real-World Anti-Vascular Endothelial Growth Factor Therapy Outcomes in Myopic Choroidal Neovascularization
por: Bhatia, Devangna, et al.
Publicado: (2021)

Targeting the m6A mRNA demethylase FTO suppresses vascular endothelial growth factor release and choroidal neovascularization
por: Wang, Shao-bin, et al.
Publicado: (2023)

Paediatric choroidal neovascular membrane secondary to toxoplasmosis treated successfully with anti-vascular endothelial growth factor
por: Mathur, Gaurav, et al.
Publicado: (2014)

Qualities for transforming a resident to be a great resident
por: Lam, Wai Yan, et al.
Publicado: (2023)

Comments on coronavirus positive patients presenting with stroke-like symptoms
por: Au, Sunny Chi Lik, et al.
Publicado: (2021)

Delayed hospital presentation of acute central retinal artery occlusion during the COVID-19 crisis: the HORA study brief report No. 4
por: Au, Sunny Chi Lik, et al.
Publicado: (2021)

Inflammatory choroidal neovascularization in Indian eyes: Etiology, clinical features, and outcomes to anti-vascular endothelial growth factor
por: Roy, Rupak, et al.
Publicado: (2017)

Reply: The role of posterior vitreous detachment on the efficacy of anti–vascular endothelial growth factor intravitreal injection for treatment of neovascular age-related macular degeneration
por: Neudorfer, Meira, et al.
Publicado: (2019)

Comment on: The role of posterior vitreous detachment on the efficacy of anti–vascular endothelial growth factor intravitreal injection for treatment of neovascular age-related macular degeneration
por: Awasthi, Upma, et al.
Publicado: (2019)

Aflibercept Treatment for Neovascular Age-related Macular Degeneration and Polypoidal Choroidal Vasculopathy Refractory to Anti-vascular Endothelial Growth Factor
por: Moon, Da Ru Chi, et al.
Publicado: (2015)

Interactions between Endostatin and Vascular Endothelial Growth Factor (VEGF) and Inhibition of Choroidal Neovascularization
por: Wang, Xun, et al.
Publicado: (2007)

Profiling neovascular age‐related macular degeneration choroidal neovascularization lesion response to anti‐vascular endothelial growth factor therapy using SSOCTA
por: Told, Reinhard, et al.
Publicado: (2020)

Anti-Vascular Endothelial Growth Factor Therapy Regimens for Polypoidal Choroidal Vasculopathy: A Systematic Review
por: Mihalache, Andrew, et al.
Publicado: (2023)

Debate on the various anti-vascular endothelial growth factor drugs
por: Khalili, Mohammad Reza, et al.
Publicado: (2008)

Long-Term Effect of Anti-Vascular Endothelial Growth Factor (Anti-VEGF) Injections in Choroidal Neovascularization Secondary to Angioid Streaks
por: Torres-Costa, Sónia, et al.
Publicado: (2022)

Incidence of outer retinal tubulation in eyes with choroidal neovascularization under intravitreal anti-vascular endothelial growth factor therapy in a Japanese population
por: Takagi, Seiji, et al.
Publicado: (2017)

Baseline predictors for good visual gains after anti-vascular endothelial growth factor therapy for myopic choroidal neovascularization
por: Hsu, Cherng-Ru, et al.
Publicado: (2022)

Aqueous Concentrations of Vascular Endothelial Growth Factor in Eyes with High Myopia with and without Choroidal Neovascularization
por: Wakabayashi, Taku, et al.
Publicado: (2013)

Intravitreal bevacizumab in choroidal neovascularization associated with Best's vitelliform dystrophy
por: Mandal, Subrata, et al.
Publicado: (2011)

Intravitreal bevacizumab for parafoveal telangiectasia-associated choroidal neovascular membrane
por: Shanmugam, Mahesh P, et al.
Publicado: (2007)

Intravitreal ranibizumab for the treatment of choroidal neovascularization secondary to ocular toxoplasmosis
por: Pandey, Neeraj, et al.
Publicado: (2013)

Relapse of choroidal neovascularization in Bietti's crystalline retinopathy following anti-vascular endothelial growth factor therapy: A case report
por: HUA, RUI, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_jbccha4l1jhg7qsuc7i2ojmk25